Aristro Capital Markets Ltd.
You Are On :   Home  |  Equity  |   Company Profile  |  Company Background
 
Equity
Equity Analysis
Price
Volume
Analysis
News Analysis
Corporate Action
Other Market
Company Profile
Company Background
Divi's Laboratories Ltd.
 
Industry : Pharmaceuticals & Drugs House : Divis Labs
BSE Code 532488
ISIN Demat INE361B01024
Book Value (Rs.) 488.01
NSE Code DIVISLAB
Dividend Yield  % 0.76
Market Cap  (Rs. Mn) 1048733.63
TTM PE (x) 76.90
TTM EPS (Rs.) 51.37
Face Value (Rs.) 2  
Incorporation Year 12-10 1990  
Registered Office 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli, Hyderabad,
Telangana-500032 .
ISINNO INE361B01024  
Phone 040 66966300  
E-mail mail@divislabs.com
URL www.divislabs.com
Industry Pharmaceuticals & Drugs  
Chairman Ramesh BV Nimmagadda  
Managing Director Murali K Divi  
Company Secretary Satish Choudhury  
Listing BSE,NSE,MCX  
close X

Download Client Registration Documents

Client Registration Documents in Vernacular Languages

Member: NSE CAPITAL MARKET: INB231498438 | NSE FUTURE & OPTION: INF231498438 | BSE CAPITAL MARKET: INB011498434 | BSE FUTURE MARKET: INF011498434 | DP REGN No.:IN-DP-CDSL-704-2013 | Single SEBI Registration nos.: NSE & BSE: INZ000219238 | DP CDSL: IN-DP-407-2019
Attention Investor: Update your mobile number and email id with your stock broker.
Home| About Us | Services | Login | Research | Online Trading | Customer Support | Useful links | SEBI SCORE | Contact Us | Investor Charter | Share Links:  
Terms & Conditions |Disclaimer | Privacy Policy |Policy & Procedure | Feedback | Open An Account | Downloads |Customer Desk |Policy |Site Map |Segregation and Monitoring of Collateral
NSE | BSE | SEBI | NSDL | NCDEX | CDSL | MCX | NMCE | MCX-SX | RBI | Do & Don'ts | CDSL Circular | CDSL e-Voting | Rights & Obligations | Risk Disclousre Document
Details of Authorised Persons | Basic Details | SMART ODR
Copyright Aristro Capital Markets Ltd. All Rights Reserved.
Designed, Developed & Content Powered By  Accord Fintech Pvt. Ltd.